Abstract | BACKGROUND AND OBJECTIVE: PATIENTS AND METHOD: A prospective study with a 6-month follow-up of patients with EMG diagnosis of primary CTS starting treatment with 1.800 mg/day of gabapentin. At baseline visit and after 6 months of treatment a complete clinical evaluation and an EMG study were performed. Adverse effects of gabapentin were also registered. RESULTS: Twenty-five patients were included, mean age (standard deviation) 58.88 (7.69) years. After 6 months of treatment, a statistically significant reduction of pain (p = 0.001) and improvement of severity of symptoms (p = 0.008) were observed, although functional capacity did not change. EMG was performed in 19 patients at 6 months. Compared to baseline EMG: 52.6% patients showed no changes in EMG findings, while 5.3% patients showed improvement and in 26.3% the EMG was normal. Progression was only seen in 15.8% of patients after 6 months of treatment. In 28% of the patients gabapentin was stopped because of side effects. CONCLUSIONS: In our series, gabapentin was effective in the reduction of pain and improvement of the severity of the symptoms. Results of EMG after 6 months of treatment showed no changes, with improvement and/or remission in 84.2% of the cases. The drug was safe and well tolerated.
|
Authors | Delia Taverner, M Pilar Lisbona, Nuria Segalés, Elisa Docampo, Joan Calvet, Sonia Castro, Pere Benito |
Journal | Medicina clinica
(Med Clin (Barc))
Vol. 130
Issue 10
Pg. 371-3
(Mar 22 2008)
ISSN: 0025-7753 [Print] Spain |
Vernacular Title | Eficacia de la gabapentina en el tratamiento del síndrome del túnel carpiano. |
PMID | 18381028
(Publication Type: Journal Article)
|
Chemical References |
- Amines
- Analgesics
- Cyclohexanecarboxylic Acids
- gamma-Aminobutyric Acid
- Gabapentin
|
Topics |
- Amines
(therapeutic use)
- Analgesics
(therapeutic use)
- Carpal Tunnel Syndrome
(drug therapy)
- Cyclohexanecarboxylic Acids
(therapeutic use)
- Electromyography
- Female
- Gabapentin
- Humans
- Male
- Middle Aged
- Prospective Studies
- gamma-Aminobutyric Acid
(therapeutic use)
|